| abstract |
The invention belongs to the technical field of traditional Chinese medicine, and in particular relates to a new medicinal use of a Sichuan zhi tongluo preparation, and a use of a chuanzhi tongluo preparation in preparing an anti-myocardial ischemia product. The invention constructs an acute myocardial ischemia model after coronary artery ligation in SD rats and a Beagle dog coronary artery ligation myocardial ischemia model, and proves through experiments that Chuanzhi Tongluo preparation has no effect on acute myocardial ischemia symptoms of the two model animals. It has a significant alleviating effect, and can significantly reduce the content of MDA, LDH and CK in the serum, improve the SOD activity in the serum, and has a significant anti-myocardial ischemia effect. |